Literature DB >> 10708061

Prevalence and route of transmission of infection with a novel DNA virus (TTV), hepatitis C virus, and hepatitis G virus in patients infected with HIV.

F Puig-Basagoiti1, M Cabana, M Guilera, M Giménez-Barcons, G Sirera, C Tural, B Clotet, J M Sánchez-Tapias, J Rodés, J C Saiz, M A Martínez.   

Abstract

OBJECTIVES: To evaluate the prevalence, route of transmission and clinical significance that current co-infection with TT virus (TTV), hepatitis C virus (HCV), and hepatitis G virus (HGV) have in HIV-1-infected patients.
DESIGN: Presence of TTV, HCV, and HGV was analyzed in plasma samples from 160 HIV-1-infected patients with parenteral (38 intravenous drug users [IVDUs] and 41 patients with hemophilia) or sexual (39 homosexuals and 42 heterosexuals) risk of exposure, and in 168 volunteer blood donors. Alanine aminotransferase (ALT) levels and CD4+ counts were also analyzed.
METHODS: HCV and HGV RNA were detected by specific reverse transcriptase (RT) nested polymerase chain reaction (PCR) and TTV DNA by specific heminested PCR.
RESULTS: TTV DNA was detected in 39% of the patients and in 14% of the volunteer blood donors. HCV and HGV infections were detected in 42% and in 14% of the patients, and in 0% and 3% of the blood donors, respectively. Prevalences of TTV and HCV infection were higher among patients with parenteral (62% and 68%) than in those with sexual (17% and 16%) risk of exposure. A higher prevalence of TTV infection (but not of HCV or HGV infection) was observed among patients with hemophilia (76%) than IVDUs (47%), and among homosexuals (26%) than among heterosexuals (10%). Abnormal ALT levels were related with the presence of HCV infection, independently of the detection of TTV DNA. TTV infection did not seem to alter the levels of CD4+ T cells.
CONCLUSIONS: Prevalence of current TTV infection is high among HIV-infected patients with parenteral risk of exposure, but TTV is also transmitted through sexual routes; detection of TTV does not seem to influence the clinical or immune status of HIV-infected patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10708061     DOI: 10.1097/00126334-200001010-00012

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  7 in total

1.  Prevalence and genotypic variability of TTV in HIV-infected patients.

Authors:  K E Sherman; S D Rouster; J Feinberg
Journal:  Dig Dis Sci       Date:  2001-11       Impact factor: 3.199

Review 2.  Transfusion transmitted virus: A review on its molecular characteristics and role in medicine.

Authors:  M Irshad; Y K Joshi; Y Sharma; I Dhar
Journal:  World J Gastroenterol       Date:  2006-08-28       Impact factor: 5.742

Review 3.  Molecular properties, biology, and clinical implications of TT virus, a recently identified widespread infectious agent of humans.

Authors:  M Bendinelli; M Pistello; F Maggi; C Fornai; G Freer; M L Vatteroni
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

4.  Role of GB virus C in HIV-1-infected and hepatitis C virus-infected hemophiliac children and adolescents.

Authors:  Solveig Tenckhoff; Thorsten Kaiser; Fritz Bredeek; Sharyne Donfield; Erika Menius; Alice Lail; Joachim Mössner; Eric S Daar; Hans L Tillmann
Journal:  J Acquir Immune Defic Syndr       Date:  2012-10-01       Impact factor: 3.731

Review 5.  Prevalence of hepatitis C virus infection among HIV+ men who have sex with men: a systematic review and meta-analysis.

Authors:  Ashly E Jordan; David C Perlman; Joshua Neurer; Daniel J Smith; Don C Des Jarlais; Holly Hagan
Journal:  Int J STD AIDS       Date:  2016-07-10       Impact factor: 1.359

6.  The Torque Teno Virus Titer in Saliva Reflects the Level of Circulating CD4+ T Lymphocytes and HIV in Individuals Undergoing Antiretroviral Maintenance Therapy.

Authors:  Layla Honorato; Steven S Witkin; Maria Cássia Mendes-Correa; Ana Luiza Castro Conde Toscano; Iara Moreno Linhares; Anderson Vicente de Paula; Heuder Gustavo Oliveira Paião; Vanessa Salete de Paula; Amanda de Oliveira Lopes; Silvia Helena Lima; Vanessa de Cássia Raymundi; Noely Evangelista Ferreira; Almir Ribeiro da Silva Junior; Karim Yaqub Abrahim; Paulo Henrique Braz-Silva; Tania Regina Tozetto-Mendoza
Journal:  Front Med (Lausanne)       Date:  2022-01-14

7.  Prevalence of GBV-C RNA in HIV infected individuals in Tehran, Iran.

Authors:  H Keyvani; A Mohammadi; M Haji-Abdolbaghi
Journal:  Iran J Public Health       Date:  2010-03-31       Impact factor: 1.429

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.